Harmony Biosciences Holdings HRMY paid LMH Strategic Solutions $30K for lobbying in Q3 2025 · Pharmacy, Medicare

Trade details

Type: Lobbying report
Amount: $30,000
Quarter: Q3 2025
Stock: Harmony Biosciences Holdings HRMY
Client: Harmony Biosciences
Reported: 25/10/20

$855K on lobbying this year

What else happened in Harmony Biosciences Holdings around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Harmony Biosciences's other lobbying reports

Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$20K
$20K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$50K
$50K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$180K
$180K
Reported 07/20
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$50K
$50K
Reported 07/05
for Q2
Harmony Biosciences
LobbyingHarmony Biosciences Holdings
Lobbying
Harmony Biosciences Holdings
HRMY
$30K
$30K
Reported 05/04
for Q1